FOXO3 and breast carcinoma: Interestingly, cytoplasmic FOXO3 was found to be positively correlated with the expression levels of SIRT6 (p < 0.001) but not SIRT1 in HER2+ (ER+ and ER−) breast cancer patients (Figure 8C).